Real-World Data on Apatinib Efficacy - Results of a Retrospective Study in Metastatic Breast Cancer Patients Pretreated With Multiline Treatment

The NCCN guidelines recommend that the addition of bevacizumab should be considered in metastatic breast cancers in some circumstances, but there are no recommendations for the similar antiangiogenic drug apatinib. The aim of this study was to evaluate the safety and efficacy of apatinib in metastat...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 11; p. 643654
Main Authors Liu, Zhaoyun, Shan, Jing, Yu, Qian, Wang, Xinzhao, Song, Xiang, Wang, Fukai, Li, Chao, Yu, Zhiyong, Yu, Jinming
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 10.06.2021
Subjects
Online AccessGet full text

Cover

Loading…